For the readers interested in the stock health of Ironwood Pharmaceuticals Inc. (IRWD). It is currently valued at $12.95. When the transactions were called off in the previous session, Stock hit the highs of $13.27, after setting-off with the price of $12.94. Company’s stock value dipped to $12.765 during the trading on the day. When the trading was stopped its value was $13.26.
Recently in News on June 16, 2021, Ironwood Pharmaceuticals Announces That The American Journal of Gastroenterology Publishes Full Results from Positive LINZESS® (linaclotide) Phase IIIb Trial in Adults with Irritable Bowel Syndrome with Constipation (IBS-C). – Results demonstrated that linaclotide improved the overall abdominal symptoms of bloating, pain and discomfort in adults with IBS-C –. You can read further details here
Ironwood Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $13.34 on 06/25/21, with the lowest value was $8.78 for the same time period, recorded on 02/26/21.
Ironwood Pharmaceuticals Inc. (IRWD) full year performance was 34.48%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Ironwood Pharmaceuticals Inc. shares are logging -2.93% during the 52-week period from high price, and 50.06% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $8.63 and $13.34.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1641117 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Ironwood Pharmaceuticals Inc. (IRWD) recorded performance in the market was 16.42%, having the revenues showcasing 22.16% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.16B, as it employees total of 232 workers.
Market experts do have their say about Ironwood Pharmaceuticals Inc. (IRWD)
During the last month, 0 analysts gave the Ironwood Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 11.48, with a change in the price was noted +3.32. In a similar fashion, Ironwood Pharmaceuticals Inc. posted a movement of +34.62% for the period of last 100 days, recording 2,069,925 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for IRWD is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 3.96.
Technical breakdown of Ironwood Pharmaceuticals Inc. (IRWD)
Raw Stochastic average of Ironwood Pharmaceuticals Inc. in the period of last 50 days is set at 82.96%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 68.78%. In the last 20 days, the company’s Stochastic %K was 75.78% and its Stochastic %D was recorded 68.41%.
Bearing in mind the latest performance of Ironwood Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 16.42%. Additionally, trading for the stock in the period of the last six months notably improved by 23.29%, alongside a boost of 34.48% for the period of the last 12 months. The shares increased approximately by 6.59% in the 7-day charts and went down by 9.86% in the period of the last 30 days. Common stock shares were driven by 22.16% during last recorded quarter.